loading page

Selection of Patients for Hybrid Ablation Procedure
  • David DeLurgio
David DeLurgio
Emory Saint Joseph's Hospital

Corresponding Author:ddelurg@emory.edu

Author Profile


Catheter ablation for treatment of symptomatic non-paroxysmal atrial fibrillation remains challenging. Clinical failure and need for continued medical therapy or repeat ablation is common, especially in more advanced forms of atrial fibrillation. Hybrid ablation has emerged as a more effective and safe therapy than endocardial-only ablation particularly for longstanding persistent atrial fibrillation as demonstrated by the randomized controlled CONVERGE trial. Hybrid ablation requires collaboration of electrophysiologists and cardiac surgeons to develop specific workflows. This review describes the Hybrid Convergent approach in the context of available ablation options and offers guidance for workflow development and patient selection.
12 Dec 2022Submitted to Journal of Cardiovascular Electrophysiology
12 Dec 2022Submission Checks Completed
12 Dec 2022Assigned to Editor
12 Dec 2022Review(s) Completed, Editorial Evaluation Pending
12 Dec 2022Reviewer(s) Assigned
10 Jan 2023Editorial Decision: Revise Minor
06 Mar 20231st Revision Received
08 Mar 2023Submission Checks Completed
08 Mar 2023Assigned to Editor
08 Mar 2023Review(s) Completed, Editorial Evaluation Pending
08 Mar 2023Reviewer(s) Assigned
26 Mar 2023Editorial Decision: Accept